The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
wrong. there is a set conversion price for 18 months. it’s all in the rns. only after that can the conversion rate be adjusted based on vwap to a price no lower than 95p. so what you’ve written there is complete ****.
Jupiter re opened a short right after TWs article before the fund raise. The sp was then held in place in the face of mass buying as they closed. TW has a link to someone who was pretty high up in either Brontë or Jupiter who write articles for one of his many sites, they actually posted an awful Avacta article, and some very shallow digging revealed their connection. On top of that there’s another writer who has links to an MM (former employee) who was heavily on the sell side at the time (can’t remember their name). It’s no coincidence that we haven’t seen the 10k seller for so long and they re appear the first trading day after his article as the SP seemed to be bouncing.
Your presence doesn’t lead to a good atmosphere on the board at all. And you know it. If you don’t realise you’re roundly hated then you’ve got some sort of personality disorder.
On another note, since TWs article on Friday we’ve had a 10k seller. Exactly the same happened after his last article. Eyes on Brontë popping up with a small short.
Then why, as I asked yesterday, don’t you sell the lot and come back in a few month wyndrum? You’ve been talking it down from 185. You claim to hold 40k shares. So why don’t you have any faith in your own opinion and bin the lot?
I don’t think the FUDs been that bad. Just lonely old harmless Wyn. Screaming at buses in between feeding pigeons while the bookies is closed.
In other news, Tom Winnitbreath has blocked me hahahahahahahhahahaahaaaaa cough
Wyn, you seem to be echoing Truants posts.
“My GUESS is that AVCT will move to 140p when the p1b starts (or a date is given for it starting)”
That also echo’s a Twitter post. Do you get all your research and ideas from Twitter now?
It’s where it is because Heights have been given free reign to just dump all their shares and take the cash. In this climate who can blame them. Stifel should have some more to control it but aren’t worth their retainer. For someone so clearly well read it’s remarkable how you manage to mis understand the difference between P1a not being your standard candidates for dox and the levels being released being of significant value within the tumour environment. Once it’s released in a tumour it is intended to treat at those levels then I can’t see how it doesn’t act like dox always does and treats the tumour. Maybe… and I’m being kind here…. You’re over thinking it?